World Health Organization (WHO)
Polidexide sulfate, an anion-exchange resin, was formerly used in
the treatment of hypercholesterolaemia. The drug, which was marketed only in the
United Kingdom, was withdrawn in the mid-1970s on the basis of new safety
findings.
